Medications to treat type-2 diabetes such as Ozempic and Semaglutide have a secondary use as rapid weight loss medications. It is so popular among...

MONDAY, July 1, 2024 -- Fewer than one-quarter of patients with type 2 diabetes (T2D) receive recommended chronic kidney disease (CKD) screening,...

There are no current treatments for non-arteritic anterior ischemic optic neuropathy (NAION) and vision often does not improve.

WEDNESDAY, June 26, 2024 -- The gut microbiome has a potential functional role in the pathogenesis of type 2 diabetes (T2D), according to a study...

TUESDAY, June 25, 2024 -- Intermittent fasting may be a more effective intervention than drugs for people with early diabetes and either obesity or...

WEDNESDAY, July 3, 2024 -- Trendy weight-loss drugs appear to increase the risk of a rare and potentially blinding eye condition, a new study...

WEDNESDAY, June 26, 2024 -- Multivitamin (MV) use is not associated with mortality benefit among U.S. adults, according to a study published online...

WEDNESDAY, July 3, 2024 -- For patients with refractory gastroesophageal reflux disease (GERD), those receiving antireflux mucosectomy (ARMS) have a...

WEDNESDAY, June 26, 2024 -- For patients with obesity-related heart failure with preserved ejection fraction (HFpEF), semaglutide reduces body weight...

WEDNESDAY, July 3, 2024 -- Endolymphatic duct blockage (EDB) is more effective than intratympanic methylprednisolone (ITMP) injection for controlling...